ATHE - Alterity Therapeutics Ltd. Kompaniya qiymatining foyda o‘sish sur’atiga nisbati
PEG koeffitsiyenti grafigi Alterity Therapeutics (ATHE) uchun ATH434 dorisi savdolari orqali neyroterapiyaning tijoratlashtirish salohiyatini namoyish etadi. 0.00 qiymati ushbu metrikaning bazaviy darajasini aks ettiradi, shu bilan birga faol loyihalar portfeli muhim II bosqich sinovlari natijalari uchun tayyorgarlik ko'rmoqda. Kompaniyaga tegishli strategiya noyob miya patologiyalari va Parkinson kasalligini davolashdagi noyob nishalarni egallashga asoslanadi.
Alterity Therapeutics (ATHE) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi haqida ma'lumot:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Alterity Therapeutics|ATHE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati alteritytherapeutics.com|ATHE - Kompaniyaning umumiy qarzi|Balans qiymatiga qarzlar Alterity Therapeutics Ltd|ATHE - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Alterity Therapeutics|Oraliq likvidlik koeffitsiyenti alteritytherapeutics.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
ATHE - Sof foyda|Kutilayotgan sof daromad Alterity Therapeutics|ATHE - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati alteritytherapeutics.com|ATHE - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Alterity Therapeutics Ltd|ATHE - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Alterity Therapeutics|ATHE - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi alteritytherapeutics.com|ATHE - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Alterity Therapeutics
Kompaniyaning jamlanma tahliliyoti:ATHE - Alterity Therapeutics Ltd.
Alterity Therapeutics (ATHE) kompaniyasini xolis baholash uchun menejer aktivning bozor qiymatini uning daromadlar dinamikasi bilan solishtirishi kerak. PEG koeffitsiyenti P/E koeffitsiyentini prognoz qilingan daromadlar o'sish sur'atiga nisbatan o'lchaydi, bunda birdan past qiymat aktivning qadrsizlanganligidan dalolat beradi. GURU.Markets platformasidagi PEG fundamental ko'rsatkichi ushbu muvozanatni dinamik tarzda kuzatish imkonini beradi. To'liq autsorsingga asoslangan ishlanmalar modelidan foydalanadigan biotexnologiya kompaniyasi uchun bu operatsion xatarlarni aniqlashda muhim filtr vazifasini o'taydi.
Alterity Therapeutics kimlar bilan raqobatlashadi
Narxning foydaga va o‘sish sur’atiga nisbati BIIB (Biogen Inc)|Neurocrine Biosciences Inc - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati RGC (Regencell Corp)|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda acadia-pharm.com|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|Viking Therapeutics Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SUPN (Supernus Pharma) - PEG multiplikatori|Catalyst Corp (CPRX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati HRMY|Biohaven - Narx-foyda va o‘sish multiplikatori|Amylyx Pharmaceuticals Inc (AMLX) - O‘sish sur’atiga tuzatilgan narx-foyda|TRVI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Corp)|AVXL (Anavex Life Sciences) - Narx-foyda va o‘sish multiplikatori|CBLL: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PRTA (Prothena Corporation plc) - PEG multiplikatori|ALEC: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANNX|OMER - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Neurogene Inc. NGNE|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACIU|Voyager Therapeutics, Inc. - PEG multiplikatori|NMRA - PEG multiplikatori|Scilex Holding Co. (SCLX) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati TVGN (Tevogen Bio Inc.)|ACOG (Alpha Cognition Inc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda cogrx.com CGTX|Narx-foyda va o‘sish multiplikatori IKT (Inhibikase Therapeutics, Inc.)|PEG multiplikatori Cassava Sciences Inc (SAVA)|Assertio - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati COYA (Coya Therapeutics Inc)|VistaGen Therapeutics Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Ovid Therapeutics Inc. OVID|ABOS: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori CervoMed, Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc|PepGen Corp (PEPG) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori JUNS|PEG multiplikatori relmada.com (RLMD)|Annovis Bio - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati GRCE (Grace Therapeutics Inc)|Firefly Neuroscience Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KLTO (Klotho Neurosciences Inc)|NRSN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda revivapharma.com (RVPH)|Narxning foydaga va o‘sish sur’atiga nisbati MetaVia Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NRXS (NeurAxis Inc.)|PEG multiplikatori HSDT|PASG - O‘sish sur’atiga tuzatilgan narx-foyda|Neuphoria Therapeutics - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori minervaneurosciences.com NERV|ATHA - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADXN (Addex Therapeutics Ltd.)|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Cyclerion Therapeutics, Inc. (CYCN)|PTIX (Protagenic Therapeutics Inc.) - PEG multiplikatori|PEG multiplikatori Pasithea|Narxning foydaga va o‘sish sur’atiga nisbati Cortigent, Inc. (CRGT)|Narxning foydaga va o‘sish sur’atiga nisbati ATXI (Avenue Therapeutics Inc.)|Brainstorm Cell Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati CARA (Cara Therapeutics Inc)|Chromocell Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Eliem Therapeutics|intracellulartherapies.com (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|Longboard Pharmaceuticals Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|MRNS (Marinus) - PEG multiplikatori|NKGen Biotech Corp (NKGN) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori NRBO (NeuroBo Pharmaceuticals)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAGE|Synaptogenix - Narx-foyda va o‘sish multiplikatori|Trevena Inc. (TRVN) - O‘sish sur’atiga tuzatilgan narx-foyda|VIGL: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical Inc.)|CERE (Cerevel Therapeutics) - Narx-foyda va o‘sish multiplikatori
